drugset / Trial / NCT01181011

Telmisartan, Amlodipine and Combination in Healthy Subjects

NCT01181011

Phase 1 Completed 28 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

To determine the pharmacokinetic profile of 80 mg telmisartan / 5 mg amlodipine (T80/A5) dose combination after single dose in healthy Chinese subjects. To determine whether a pharmacokinetic interaction exists between telmisartan and amlodipine, following single doses of 80mg telmisartan (T80), and 5 mg amlodipine (A5) tablet alone and in combination, in healthy Chinese subjects. To evaluate the safety and tolerability of T80 and A5 alone and in combination in healthy Chinese subjects.

Timeline

Start
2010-08
Primary completion
2010-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg
Subject Telmisartan Other / unclassified 80 mg

Indications

No indication recorded.